Effect of a consultant pharmacist on medication use in an institution for the mentally retarded

Berchou, Richard

doi:10.1093/ajhp/39.10.1671

Cited by 13 publications

(25 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42] The investigation sites were divided equally between inpatient and outpatient facilities. Four studies took place in an inpatient psychiatric facility, 32,34,35,39 four in outpatient psychiatric clinics, [27][28][29]36 four in primary care clinics, 37, 40-42 three at institutions for the mentally retarded, 27,31,33 and one in a series of nursing homes. 38 The affiliated health care systems were primarily closed staff models, five in the Veterans Administration system and five at other staff model health maintenance organizations (HMOs).…”

Section: Search Resultsmentioning

confidence: 99%

“…All the investigations involved patient populations except one, which examined an educational intervention involving providers. 37 Patient populations included those with schizophrenia (one inpatient and one outpatient), 29,35 depression (three outpatient), [40][41][42] behavioral disturbances (four outpatient), 27,31,33,38 and general psychopathology or different diagnoses (three inpatient and three outpatient). 28,30,32,34,36,39 The most common intervention (nine studies) consisted of clinical pharmacists providing a combination of drug monitoring (baseline assessment and treatment follow-up), treatment recommendations, and patient education.…”

Section: Search Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Evaluating the Impact of Pharmacists in Mental Health: A Systematic Review

2003

View full text Add to dashboard Cite

Efforts to improve the outcomes of patients with mental illness often have involved incorporating the skills of a variety of health care professionals into collaborative care models. For over 30 years, clinical pharmacists have contributed to these care models in capacities ranging from educator to consultant to provider. This systematic review evaluates the quantity and quality of medical literature examining the impact of pharmacists in mental health from 1972-2003. Although we identified approximately 35 publications describing the roles of clinical pharmacists in this regard, only 16 were of sufficient scientific rigor to permit evaluation and comparison. The 16 studies were divided equally between inpatient and outpatient settings and were conducted in a variety of health care organizations (e.g., Veterans Administration, health maintenance organizations, community mental health clinics, and nursing homes). Nine of the studies examined the role of pharmacists in providing treatment recommendations and patient education, five featured pharmacists as providers (with prescriptive authority), and the remaining two described the impact pharmacists have in delivering education to the psychiatric staff. Six of the 16 studies were prospective, but only three of these incorporated a randomization procedure for patients or facilities. Collectively, the results of the 16 studies were positive, demonstrating improvements in outcomes, prescribing practices, patient satisfaction, and resource use. Unfortunately, most of the investigations were small, and significant limitations in study design limited further comparison. Given the long history and anecdotal success of pharmacists in mental health care settings, additional multicenter cost-effectiveness trials are warranted to further support the role of the psychiatric pharmacist.

show abstract

Section: Search Resultsmentioning

confidence: 99%

Section: Search Resultsmentioning

confidence: 99%

Evaluating the Impact of Pharmacists in Mental Health: A Systematic Review

2003

View full text Add to dashboard Cite

show abstract

“…Early work in this area focused upon a role for clinical pharmacists in nonacute settings, such as long-term care facilities for intellectually disabled patients. Berchou demonstrated that pharmacy input in the multidisciplinary care of intellectually disabled patients was associated with a significant increase in the use of antipsychotic and anticonvulsant monotherapy (14).…”

Section: Discussionmentioning

confidence: 99%

A prospective analysis of clinical pharmacy interventions on an acute psychiatric inpatient unit

Alderman

1997

Journal of Clinical Pharmacy and Therapeutics

View full text Add to dashboard Cite

A standardized data collection form was developed to enable uniform documentation of all clinical pharmacy interventions undertaken for an acute-care, psychiatric inpatient population during a 6-month study period. This information included demographic data as well as details of the drugs involved, the nature of the drug-related problems, the type of intervention and an estimate of the significance of the intervention. A total of 204 clinical interventions were proposed for 69 patients (mean age 66.8 years, range 28-85 years). The proposed interventions were accepted by medical staff in 187 (91.7%) instances. Antidepressants were the class of drug most often generating clinical interventions (34.7% of total interventions). The most common type of intervention was a recommendation for the commencement of drug therapy (28.8%), followed by recommendations for enhanced patient monitoring (23.5%). In 20.3% of cases the interventions were estimated to be of major significance. This study suggests that the provision of clinical pharmacy services in the acute-care, adult, psychiatric setting has the potential to generate a considerable range of interventions aimed at optimizing treatment outcomes.

show abstract

“…Skaled et al describe the favourable impact of clinical pharmacy services on both the process and outcome of health care measures in a unit admitting acute adult psychiatric patients (4). Berchov reported on the positive effect of a consultant psychopharmacist on the quality of psychotropic and anticonvulsant drug use in a long-term mental retardation facility (5). Dorevitch et al describe the impact of a psychiatric clinical pharmacist acting as a primary clinician under the supervision of the attending psychiatrist in medication maintenance of chronic schizophrenic outpatients (6).…”

Section: Introductionmentioning

confidence: 99%

The impact of clinical pharmacy intervention in a psychiatric hospital

A¹,

Perl²

1996

J Clin Pharm Ther

View full text Add to dashboard Cite

One hundred and nine physician-initiated consultations were directed to a clinical pharmacist over a 1-year period. Two hundred and three (88·2%) recommendations out of 229 were adopted. Major question types included preventive measures, non-response, side-effects and mixed factors. The global effectiveness of pharmacist interventions suggests that 67·9% of patients exhibited a very satisfactory or satisfactory response. While our study suggests that a clinical pharmacist may favourably contribute to the quality of patient care, a control-group study is required to confirm our results.

show abstract

Effect of a consultant pharmacist on medication use in an institution for the mentally retarded

Cited by 13 publications

References 0 publications

Evaluating the Impact of Pharmacists in Mental Health: A Systematic Review

Evaluating the Impact of Pharmacists in Mental Health: A Systematic Review

A prospective analysis of clinical pharmacy interventions on an acute psychiatric inpatient unit

The impact of clinical pharmacy intervention in a psychiatric hospital

Contact Info

Product

Resources

About